Miscellaneous Antimalarials Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Type (Doxycyline, Pyrimethamine, Halofantrine); Distribution Channel (Retail Pharmacies, Online Pharmacy, Hospital Pharmacies); Application (Treatment, Prevention) and Geography

Report Code: TIPRE00018985 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Malaria is an infectious disease cause by bite of female anopheles mosquito mainly of plasmodium parasite. After mosquito bite the parasites enters the bloodstream further they mature in liver and begins to infect red blood cells. Malaria is generally characterized by recurrent chills, fever along with enlarged spleen. The common symptom of malaria include, fever, vomiting and tiredness. Miscellaneous antimalarials are the agents used to treat malarial infection. The miscellaneous drugs include, halofantrine, doxycycline.

MARKET DYNAMICS

The key market drivers for Miscellaneous Antimalarials Market Includes, increasing prevalence of malaria across the globe along with various initiatives taken by government to spread awareness about malaria. Moreover, presence of robust pipeline for therapeutic agents is also expected to boost market growth. However, lack of awareness about health and clean environment in developing nations is expected to restrain market growth during forecast period.

MARKET SCOPE

The "Miscellaneous Antimalarials Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Miscellaneous Antimalarials market with detailed market segmentation by drug type, distribution channel, application. The Miscellaneous Antimalarials Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Miscellaneous Antimalarials Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Miscellaneous Antimalarials Market is segmented on the basis of drug type, distribution channel, application. On the basis of drug type the market is segmented as, doxycycline, pyrimethamine, halofantrine. On the basis of distribution channel the market is segmented as, retail pharmacies, online pharmacy, hospital pharmacies. And on the basis of application the market is segmented as, treatment and prevention.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Miscellaneous Antimalarials Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Miscellaneous Antimalarials Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Miscellaneous Antimalarials Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Miscellaneous Antimalarials Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Miscellaneous Antimalarials Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Miscellaneous Antimalarials Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Miscellaneous Antimalarials market in the global market. Below mentioned is the list of few companies engaged in the Miscellaneous Antimalarials Market.

The report also includes the profiles of key players in Miscellaneous Antimalarials Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Novartis
  •   Sanofi S.A
  •   Glenmark
  •   GlaxoSmithKline plc.
  •   Teva Pharmaceutical Industries
  •   Paso Laboratories
  •   Bayer AG
  •   Milan Pharmaceuticals
  •   IPCA Laboratories, Inc.
  •   Zydus Cadila

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Miscellaneous Antimalarials Market - By Drug Type
1.3.2 Miscellaneous Antimalarials Market - By Distribution Channel
1.3.3 Miscellaneous Antimalarials Market - By Application
1.3.4 Miscellaneous Antimalarials Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. MISCELLANEOUS ANTIMALARIALS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. MISCELLANEOUS ANTIMALARIALS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. MISCELLANEOUS ANTIMALARIALS MARKET - GLOBAL MARKET ANALYSIS
6.1. MISCELLANEOUS ANTIMALARIALS - GLOBAL MARKET OVERVIEW
6.2. MISCELLANEOUS ANTIMALARIALS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. MISCELLANEOUS ANTIMALARIALS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. DOXYCYLINE
7.3.1. Overview
7.3.2. Doxycyline Market Forecast and Analysis
7.4. PYRIMETHAMINE
7.4.1. Overview
7.4.2. Pyrimethamine Market Forecast and Analysis
7.5. HALOFANTRINE
7.5.1. Overview
7.5.2. Halofantrine Market Forecast and Analysis
8. MISCELLANEOUS ANTIMALARIALS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. RETAIL PHARMACIES
8.3.1. Overview
8.3.2. Retail Pharmacies Market Forecast and Analysis
8.4. ONLINE PHARMACY
8.4.1. Overview
8.4.2. Online Pharmacy Market Forecast and Analysis
8.5. HOSPITAL PHARMACIES
8.5.1. Overview
8.5.2. Hospital Pharmacies Market Forecast and Analysis
9. MISCELLANEOUS ANTIMALARIALS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. TREATMENT
9.3.1. Overview
9.3.2. Treatment Market Forecast and Analysis
9.4. PREVENTION
9.4.1. Overview
9.4.2. Prevention Market Forecast and Analysis

10. MISCELLANEOUS ANTIMALARIALS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Miscellaneous Antimalarials Market Overview
10.1.2 North America Miscellaneous Antimalarials Market Forecasts and Analysis
10.1.3 North America Miscellaneous Antimalarials Market Forecasts and Analysis - By Drug Type
10.1.4 North America Miscellaneous Antimalarials Market Forecasts and Analysis - By Distribution Channel
10.1.5 North America Miscellaneous Antimalarials Market Forecasts and Analysis - By Application
10.1.6 North America Miscellaneous Antimalarials Market Forecasts and Analysis - By Countries
10.1.6.1 United States Miscellaneous Antimalarials Market
10.1.6.1.1 United States Miscellaneous Antimalarials Market by Drug Type
10.1.6.1.2 United States Miscellaneous Antimalarials Market by Distribution Channel
10.1.6.1.3 United States Miscellaneous Antimalarials Market by Application
10.1.6.2 Canada Miscellaneous Antimalarials Market
10.1.6.2.1 Canada Miscellaneous Antimalarials Market by Drug Type
10.1.6.2.2 Canada Miscellaneous Antimalarials Market by Distribution Channel
10.1.6.2.3 Canada Miscellaneous Antimalarials Market by Application
10.1.6.3 Mexico Miscellaneous Antimalarials Market
10.1.6.3.1 Mexico Miscellaneous Antimalarials Market by Drug Type
10.1.6.3.2 Mexico Miscellaneous Antimalarials Market by Distribution Channel
10.1.6.3.3 Mexico Miscellaneous Antimalarials Market by Application
10.2. EUROPE
10.2.1 Europe Miscellaneous Antimalarials Market Overview
10.2.2 Europe Miscellaneous Antimalarials Market Forecasts and Analysis
10.2.3 Europe Miscellaneous Antimalarials Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Miscellaneous Antimalarials Market Forecasts and Analysis - By Distribution Channel
10.2.5 Europe Miscellaneous Antimalarials Market Forecasts and Analysis - By Application
10.2.6 Europe Miscellaneous Antimalarials Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Miscellaneous Antimalarials Market
10.2.6.1.1 Germany Miscellaneous Antimalarials Market by Drug Type
10.2.6.1.2 Germany Miscellaneous Antimalarials Market by Distribution Channel
10.2.6.1.3 Germany Miscellaneous Antimalarials Market by Application
10.2.6.2 France Miscellaneous Antimalarials Market
10.2.6.2.1 France Miscellaneous Antimalarials Market by Drug Type
10.2.6.2.2 France Miscellaneous Antimalarials Market by Distribution Channel
10.2.6.2.3 France Miscellaneous Antimalarials Market by Application
10.2.6.3 Italy Miscellaneous Antimalarials Market
10.2.6.3.1 Italy Miscellaneous Antimalarials Market by Drug Type
10.2.6.3.2 Italy Miscellaneous Antimalarials Market by Distribution Channel
10.2.6.3.3 Italy Miscellaneous Antimalarials Market by Application
10.2.6.4 Spain Miscellaneous Antimalarials Market
10.2.6.4.1 Spain Miscellaneous Antimalarials Market by Drug Type
10.2.6.4.2 Spain Miscellaneous Antimalarials Market by Distribution Channel
10.2.6.4.3 Spain Miscellaneous Antimalarials Market by Application
10.2.6.5 United Kingdom Miscellaneous Antimalarials Market
10.2.6.5.1 United Kingdom Miscellaneous Antimalarials Market by Drug Type
10.2.6.5.2 United Kingdom Miscellaneous Antimalarials Market by Distribution Channel
10.2.6.5.3 United Kingdom Miscellaneous Antimalarials Market by Application
10.2.6.6 Rest of Europe Miscellaneous Antimalarials Market
10.2.6.6.1 Rest of Europe Miscellaneous Antimalarials Market by Drug Type
10.2.6.6.2 Rest of Europe Miscellaneous Antimalarials Market by Distribution Channel
10.2.6.6.3 Rest of Europe Miscellaneous Antimalarials Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Miscellaneous Antimalarials Market Overview
10.3.2 Asia-Pacific Miscellaneous Antimalarials Market Forecasts and Analysis
10.3.3 Asia-Pacific Miscellaneous Antimalarials Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Miscellaneous Antimalarials Market Forecasts and Analysis - By Distribution Channel
10.3.5 Asia-Pacific Miscellaneous Antimalarials Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Miscellaneous Antimalarials Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Miscellaneous Antimalarials Market
10.3.6.1.1 Australia Miscellaneous Antimalarials Market by Drug Type
10.3.6.1.2 Australia Miscellaneous Antimalarials Market by Distribution Channel
10.3.6.1.3 Australia Miscellaneous Antimalarials Market by Application
10.3.6.2 China Miscellaneous Antimalarials Market
10.3.6.2.1 China Miscellaneous Antimalarials Market by Drug Type
10.3.6.2.2 China Miscellaneous Antimalarials Market by Distribution Channel
10.3.6.2.3 China Miscellaneous Antimalarials Market by Application
10.3.6.3 India Miscellaneous Antimalarials Market
10.3.6.3.1 India Miscellaneous Antimalarials Market by Drug Type
10.3.6.3.2 India Miscellaneous Antimalarials Market by Distribution Channel
10.3.6.3.3 India Miscellaneous Antimalarials Market by Application
10.3.6.4 Japan Miscellaneous Antimalarials Market
10.3.6.4.1 Japan Miscellaneous Antimalarials Market by Drug Type
10.3.6.4.2 Japan Miscellaneous Antimalarials Market by Distribution Channel
10.3.6.4.3 Japan Miscellaneous Antimalarials Market by Application
10.3.6.5 South Korea Miscellaneous Antimalarials Market
10.3.6.5.1 South Korea Miscellaneous Antimalarials Market by Drug Type
10.3.6.5.2 South Korea Miscellaneous Antimalarials Market by Distribution Channel
10.3.6.5.3 South Korea Miscellaneous Antimalarials Market by Application
10.3.6.6 Rest of Asia-Pacific Miscellaneous Antimalarials Market
10.3.6.6.1 Rest of Asia-Pacific Miscellaneous Antimalarials Market by Drug Type
10.3.6.6.2 Rest of Asia-Pacific Miscellaneous Antimalarials Market by Distribution Channel
10.3.6.6.3 Rest of Asia-Pacific Miscellaneous Antimalarials Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Miscellaneous Antimalarials Market Overview
10.4.2 Middle East and Africa Miscellaneous Antimalarials Market Forecasts and Analysis
10.4.3 Middle East and Africa Miscellaneous Antimalarials Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Miscellaneous Antimalarials Market Forecasts and Analysis - By Distribution Channel
10.4.5 Middle East and Africa Miscellaneous Antimalarials Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Miscellaneous Antimalarials Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Miscellaneous Antimalarials Market
10.4.6.1.1 South Africa Miscellaneous Antimalarials Market by Drug Type
10.4.6.1.2 South Africa Miscellaneous Antimalarials Market by Distribution Channel
10.4.6.1.3 South Africa Miscellaneous Antimalarials Market by Application
10.4.6.2 Saudi Arabia Miscellaneous Antimalarials Market
10.4.6.2.1 Saudi Arabia Miscellaneous Antimalarials Market by Drug Type
10.4.6.2.2 Saudi Arabia Miscellaneous Antimalarials Market by Distribution Channel
10.4.6.2.3 Saudi Arabia Miscellaneous Antimalarials Market by Application
10.4.6.3 Rest of Middle East and Africa Miscellaneous Antimalarials Market
10.4.6.3.1 Rest of Middle East and Africa Miscellaneous Antimalarials Market by Drug Type
10.4.6.3.2 Rest of Middle East and Africa Miscellaneous Antimalarials Market by Distribution Channel
10.4.6.3.3 Rest of Middle East and Africa Miscellaneous Antimalarials Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Miscellaneous Antimalarials Market Overview
10.5.2 South and Central America Miscellaneous Antimalarials Market Forecasts and Analysis
10.5.3 South and Central America Miscellaneous Antimalarials Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Miscellaneous Antimalarials Market Forecasts and Analysis - By Distribution Channel
10.5.5 South and Central America Miscellaneous Antimalarials Market Forecasts and Analysis - By Application
10.5.6 South and Central America Miscellaneous Antimalarials Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Miscellaneous Antimalarials Market
10.5.6.1.1 Brazil Miscellaneous Antimalarials Market by Drug Type
10.5.6.1.2 Brazil Miscellaneous Antimalarials Market by Distribution Channel
10.5.6.1.3 Brazil Miscellaneous Antimalarials Market by Application
10.5.6.2 Argentina Miscellaneous Antimalarials Market
10.5.6.2.1 Argentina Miscellaneous Antimalarials Market by Drug Type
10.5.6.2.2 Argentina Miscellaneous Antimalarials Market by Distribution Channel
10.5.6.2.3 Argentina Miscellaneous Antimalarials Market by Application
10.5.6.3 Rest of South and Central America Miscellaneous Antimalarials Market
10.5.6.3.1 Rest of South and Central America Miscellaneous Antimalarials Market by Drug Type
10.5.6.3.2 Rest of South and Central America Miscellaneous Antimalarials Market by Distribution Channel
10.5.6.3.3 Rest of South and Central America Miscellaneous Antimalarials Market by Application

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. MISCELLANEOUS ANTIMALARIALS MARKET, KEY COMPANY PROFILES
12.1. NOVARTIS
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SANOFI S.A
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLENMARK
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GLAXOSMITHKLINE PLC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. TEVA PHARMACEUTICAL INDUSTRIES
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. PASO LABORATORIES
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BAYER AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MILAN PHARMACEUTICALS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. IPCA LABORATORIES, INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ZYDUS CADILA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Novartis
2. Sanofi S.A
3. Glenmark
4. GlaxoSmithKline Plc
5. Teva Pharmaceutical Industries
6. Paso Laboratories
7. Bayer AG
8. Milan Pharmaceuticals
9. IPCA Laboratories, Inc
10. Zydus Cadila
TIPRE00018985
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking